Jerry Colca

Jerry Colca

Company: Cirius Therapeutics

Job title: CSO

Seminars:

New Insulin Sensitizers as a Golden Combination With Glp-1 & Weight Loss Therapies 9:00 am - 10:00 am

Discussing novel oral insulin sensitizers targeting the mitochondrial pyruvate carrier to improve insulin sensitivity by shifting mitochondrial metabolism, increasing insulin response, and enhancing mitochondrial function Exploring insulin sensitizers beyond glycaemic control such as their potential to increase lean muscle mass and inflammation modulation Developing potent insulin-sensitising drugs that can be used in combination with GLP-1…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.